This brief assessment is designed to help health plans evaluate how effectively they are managing members with chronic kidney disease (CKD) and end-stage renal disease (ESRD).

At the end of the assessment, you’ll receive:

  • A peer-relative performance analysis
  • A CKD/ESRD opportunity snapshot
  • Guidance on where improvement is possible

You may skip any question by selecting “not sure.” We do not ask for member-level information or PHI, and all responses are confidential.

Kidney disease represents a significant, under-managed opportunity for better clinical outcomes, cost-avoidance, quality improvement, and downstream risk reduction across all lines of business, including Medicaid, Medicare Advantage, DSNP, CSNP, Commercial, and Marketplace populations.

The team at Healthmap Solutions developed this assessment tool based on our years of experience helping health plans across the U.S. manage their kidney disease populations. Whether your result in this assessment is Green, Yellow, or Red, Healthmap Solutions can help your health plan improve clinical outcomes, deliver on proven guaranteed savings, and provide operational and service excellence at best practice levels.

Loading assessment…

Tier 1: Advanced

Top-quartile performance vs. peer plans

What this means:
Your organization is ahead of most peer plans in identifying and managing CKD/ESRD populations, with strong foundations in place across risk stratification and care management. However, even leading plans can have gaps in identification and consistent engagement across the full CKD/ESRD spectrum.

The opportunity:
Peer performance at this level often unlocks additional value through more targeted, scalable interventions, particularly by earlier identification and improving engagement consistency. This can result in incremental cost savings and slowed disease progression.

Let's turn your Green score into CKD/ESRD population management best practices!

CONTACT AN EXPERT

Tier 2: Developing

Middle-of-the-pack performance

What this means:
You are addressing CKD, but important gaps likely exist in identification, engagement, and/or progression management that are limiting overall clinical impact and financial results.

The opportunity:
Health plans in this tier can often reduce avoidable utilization, costs, and disease progression by implementing more systemic, data-driven CKD programs that are managed by kidney health experts.

Let's take your Yellow score and move your health plan to top-quartile performance!

CONTACT AN EXPERT

Tier 3: At-Risk

Below-benchmark performance

What this means:
Your health plan probably has member identification and engagement challenges and may be missing a significant portion of CKD/ESRD members or engaging them too late to materially impact clinical and financial outcomes.

The opportunity:
Early-stage CKD intervention represents one of the highest ROI opportunities in population health. Plans that establish a more proactive, structured approach to identification and engagement often see substantial improvements in both cost and clinical outcomes.

Let's take your Red score and move your health plan to top-quartile performance!

CONTACT AN EXPERT